MCID: PTY001
MIFTS: 42

Pityriasis Rosea malady

Categories: Skin diseases

Aliases & Classifications for Pityriasis Rosea

Aliases & Descriptions for Pityriasis Rosea:

Name: Pityriasis Rosea 12 42 14 69
Pityriasis Circinata 12

Classifications:



External Ids:

Disease Ontology 12 DOID:8892
ICD10 33 L42
ICD9CM 35 696.3
MeSH 42 D017515
NCIt 47 C26855
SNOMED-CT 64 156373006 77252004
UMLS 69 C0032026

Summaries for Pityriasis Rosea

MalaCards based summary : Pityriasis Rosea, also known as pityriasis circinata, is related to hepatitis and pityriasis rotunda. An important gene associated with Pityriasis Rosea is HLA-C (Major Histocompatibility Complex, Class I, C), and among its related pathways/superpathways are Innate Immune System and Class I MHC mediated antigen processing and presentation. The drugs Tacrolimus and Petrolatum have been mentioned in the context of this disorder. Affiliated tissues include skin, t cells and testes, and related phenotype is Increased shRNA abundance (Z-score > 2).

Wikipedia : 71 Pityriasis rosea (also known as pityriasis rosea Gibert) is a skin rash. It is benign but may inflict... more...

Related Diseases for Pityriasis Rosea

Diseases related to Pityriasis Rosea via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 121)
id Related Disease Score Top Affiliating Genes
1 hepatitis 29.9 HLA-A HLA-B HLA-C HLA-DRB1
2 pityriasis rotunda 11.4
3 psoriasis 10.2
4 mirizzi syndrome 10.2 HLA-B HLA-DRB1
5 kernicterus due to isoimmunization 10.2 HLA-C HLA-DRB1
6 swine influenza 10.2 HLA-B HLA-DRB1
7 solid pseudopapillary carcinoma of pancreas 10.2 HLA-A HLA-B
8 myopathy, congenital nonprogressive, with moebius sequence and robin sequence 10.2 HLA-A HLA-B
9 dermatitis 10.2
10 pseudohypoparathyroidism 10.2 HLA-C HLA-DRB1
11 aortic coarctation 10.1 HLA-A HLA-B
12 bubonic plague 10.1 HLA-A HLA-B
13 epstein-barr virus, susceptibility to chronic infection by 10.1 HLA-A HLA-C
14 gonococcal endophthalmia 10.1 HLA-A HLA-B
15 apple allergy 10.1 HLA-DQB1 HLA-DRB1
16 hemoglobin d disease 10.1 HLA-DQB1 HLA-DRB1
17 cerebral sarcoidosis 10.1 HLA-A HLA-DRB1
18 bilateral parasagittal parieto-occipital polymicrogyria 10.1 HLA-DQB1 HLA-DRB1
19 lin-gettig syndrome 10.1 HLA-DQB1 HLA-DRB1
20 midline interhemispheric variant of holoprosencephaly 10.1 HLA-DQB1 HLA-DRB1
21 mastitis 10.1 HLA-A HLA-B
22 autosomal dominant intermediate charcot-marie-tooth 10.1 HLA-DQB1 HLA-DRB1
23 renal agenesis meningomyelocele mullerian defect 10.1 HLA-DQB1 HLA-DRB1
24 lyme disease - neurological complications 10.1 HLA-DQB1 HLA-DRB1
25 distal trisomy 14q 10.1 HLA-DQB1 HLA-DRB1
26 linear lichen planus 10.1 HLA-DQB1 HLA-DRB1
27 myeloid and lymphoid neoplasms with eosinophilia and abnormalities of pdgfra, pdgfrb, and fgfr1 10.1 HLA-B HLA-DQB1
28 night blindness 10.1 HLA-DQB1 HLA-DRB1
29 motility-related diarrhea 10.1 HLA-A HLA-DRB1
30 neonatal antiphospholipid syndrome 10.1 HLA-DQB1 HLA-DRB1
31 rete testis adenocarcinoma 10.1 HLA-A HLA-DQB1
32 disease of mental health 10.1 HLA-B HLA-DRB1
33 urethral gland abscess 10.1 HLA-C HLA-DRB1
34 plummer's disease 10.1 HLA-DRB1 HLA-DRB5
35 lichen planus 10.1
36 clostridium difficile colitis 10.1 HLA-DQB1 HLA-DRB1
37 myofibroma 10.1 HLA-DQB1 HLA-DRB1
38 central nervous system lymphoma 10.1 HLA-A HLA-B
39 oromandibular dystonia 10.1 HLA-DQB1 HLA-DRB1
40 patau syndrome 10.1 HLA-A HLA-DRB1
41 acute cholangitis 10.1 HLA-B HLA-C HLA-DRB1
42 molybdenum cofactor deficiency a 10.1 HLA-B HLA-C HLA-DRB1
43 epididymo-orchitis 10.0 HLA-A HLA-B HLA-C
44 colorectal cancer, hereditary nonpolyposis, type 6 10.0 HLA-A HLA-B HLA-C
45 low anorectal malformation 10.0 HLA-DQB1 HLA-DRB1
46 hashimoto's encephalitis 10.0 HLA-DRB1 HLA-DRB4
47 orbital osteomyelitis 10.0 HLA-A HLA-B HLA-C
48 autosomal recessive congenital methemoglobinemia 10.0 HLA-A HLA-B HLA-C
49 psoriasis susceptibility 1 10.0 HLA-A HLA-B HLA-C
50 ragweed sensitivity 10.0 HLA-DQB1 HLA-DRB1

Graphical network of the top 20 diseases related to Pityriasis Rosea:



Diseases related to Pityriasis Rosea

Symptoms & Phenotypes for Pityriasis Rosea

GenomeRNAi Phenotypes related to Pityriasis Rosea according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-103 10.82 HLA-B HLA-C HLA-A
2 Increased shRNA abundance (Z-score > 2) GR00366-A-110 10.82 HLA-C HLA-A HLA-B
3 Increased shRNA abundance (Z-score > 2) GR00366-A-118 10.82 HLA-B HLA-C HLA-A
4 Increased shRNA abundance (Z-score > 2) GR00366-A-12 10.82 HLA-DRB4
5 Increased shRNA abundance (Z-score > 2) GR00366-A-124 10.82 HLA-C
6 Increased shRNA abundance (Z-score > 2) GR00366-A-127 10.82 HLA-DRB4
7 Increased shRNA abundance (Z-score > 2) GR00366-A-130 10.82 HLA-DRB4
8 Increased shRNA abundance (Z-score > 2) GR00366-A-137 10.82 HLA-DRB4
9 Increased shRNA abundance (Z-score > 2) GR00366-A-149 10.82 HLA-C
10 Increased shRNA abundance (Z-score > 2) GR00366-A-156 10.82 HLA-B HLA-C HLA-A
11 Increased shRNA abundance (Z-score > 2) GR00366-A-162 10.82 HLA-C
12 Increased shRNA abundance (Z-score > 2) GR00366-A-174 10.82 HLA-DRB4
13 Increased shRNA abundance (Z-score > 2) GR00366-A-176 10.82 HLA-DRB5
14 Increased shRNA abundance (Z-score > 2) GR00366-A-177 10.82 HLA-DRB4 HLA-DRB5
15 Increased shRNA abundance (Z-score > 2) GR00366-A-178 10.82 HLA-B HLA-C HLA-A HLA-DRB5
16 Increased shRNA abundance (Z-score > 2) GR00366-A-185 10.82 HLA-DRB4
17 Increased shRNA abundance (Z-score > 2) GR00366-A-19 10.82 HLA-B HLA-C HLA-A
18 Increased shRNA abundance (Z-score > 2) GR00366-A-196 10.82 HLA-DRB4
19 Increased shRNA abundance (Z-score > 2) GR00366-A-2 10.82 HLA-DRB4
20 Increased shRNA abundance (Z-score > 2) GR00366-A-202 10.82 HLA-C
21 Increased shRNA abundance (Z-score > 2) GR00366-A-31 10.82 HLA-C HLA-A HLA-B HLA-DRB4
22 Increased shRNA abundance (Z-score > 2) GR00366-A-42 10.82 HLA-DRB4
23 Increased shRNA abundance (Z-score > 2) GR00366-A-46 10.82 HLA-DRB4
24 Increased shRNA abundance (Z-score > 2) GR00366-A-47 10.82 HLA-C
25 Increased shRNA abundance (Z-score > 2) GR00366-A-67 10.82 HLA-DRB4
26 Increased shRNA abundance (Z-score > 2) GR00366-A-7 10.82 HLA-B HLA-C HLA-A
27 Increased shRNA abundance (Z-score > 2) GR00366-A-70 10.82 HLA-DRB4
28 Increased shRNA abundance (Z-score > 2) GR00366-A-74 10.82 HLA-B HLA-C HLA-A
29 Increased shRNA abundance (Z-score > 2) GR00366-A-81 10.82 HLA-DRB5
30 Increased shRNA abundance (Z-score > 2) GR00366-A-93 10.82 HLA-C

Drugs & Therapeutics for Pityriasis Rosea

Drugs for Pityriasis Rosea (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 14)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Tacrolimus Approved, Investigational Phase 4 104987-11-3 445643 439492
2
Petrolatum Approved Phase 4 8009-03-8
3
Calcitriol Approved, Nutraceutical Phase 4 32222-06-3 134070 5280453
4 vitamin d Phase 4
5 Dermatologic Agents Phase 4
6 Trace Elements Phase 4
7 Vasoconstrictor Agents Phase 4
8 Emollients Phase 4
9 Vitamins Phase 4
10 Immunosuppressive Agents Phase 4
11 Micronutrients Phase 4
12 Bone Density Conservation Agents Phase 4
13 Calcineurin Inhibitors Phase 4
14 Calcium, Dietary Phase 4

Interventional clinical trials:


id Name Status NCT ID Phase
1 Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis Alba Completed NCT01388517 Phase 4

Search NIH Clinical Center for Pityriasis Rosea

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: pityriasis rosea

Genetic Tests for Pityriasis Rosea

Anatomical Context for Pityriasis Rosea

MalaCards organs/tissues related to Pityriasis Rosea:

39
Skin, T Cells, Testes, Bone, Myeloid, Bone Marrow, Tongue

Publications for Pityriasis Rosea

Articles related to Pityriasis Rosea:

(show top 50) (show all 403)
id Title Authors Year
1
The role of interleukin-22 in pityriasis rosea. ( 27862158 )
2017
2
Diagnosis and management of pityriasis rosea. ( 28002142 )
2017
3
Atypical pityriasis rosea presenting with a herald patch lesion on the healed site of herpes zoster: Wolf's isotopic response. ( 26678150 )
2016
4
A position statement on the management of patients with pityriasis rosea. ( 27406919 )
2016
5
Pityriasis rosea along Blaschko's lines: A rare variant. ( 27852994 )
2016
6
Pityriasis rosea: a natural history of pediatric cases in theCentral Anatolia Region of Turkey. ( 28081320 )
2016
7
Atypical pityriasis rosea: clinical evaluation of 27 patients. ( 27558764 )
2016
8
Pityriasis rosea in pregnancy: report of a spousal occurrence and craniosynostosis in the healthy newborn. ( 27648382 )
2016
9
Pityriasis Rosea, Gianotti-Crosti Syndrome, Asymmetric Periflexural Exanthem, Papular-Purpuric Gloves and Socks Syndrome, Eruptive Pseudoangiomatosis, and Eruptive Hypomelanosis: Do Their Epidemiological Data Substantiate Infectious Etiologies? ( 27103975 )
2016
10
Pityriasis Rosea: A Comprehensive Classification. ( 27096928 )
2016
11
Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects. ( 27512182 )
2016
12
Salute sign: A nonambiguous histopathological sign in pityriasis rosea. ( 27990399 )
2016
13
Red Cell Distribution Width and Mean Platelet Volume in Patients With Pityriasis Rosea. ( 27222672 )
2016
14
Is a treatment for pityriasis rosea really needed? ( 27730050 )
2016
15
The Oxidant and Antioxidant Status in Pityriasis Rosea. ( 26955119 )
2016
16
A Herald Patch Almost Encircling the Trunk-Extreme Pityriasis Rosea Gigantea in a Young Child. ( 27396667 )
2016
17
A case series of erythema multiforme-like pityriasis rosea. ( 27294066 )
2016
18
Anesthetic Considerations for Neuraxial Anesthesia in Pregnant Patients With Pityriasis Rosea With Skin Lesions Covering the Lumbar Spine. ( 27513966 )
2016
19
Acyclovir is not effective in pityriasis rosea: Results of a randomized, triple-blind, placebo-controlled trial. ( 27212277 )
2016
20
Pityriasis rosea-like adverse reaction to atenolol. ( 25791321 )
2015
21
Narrowband UVB phototherapy in pityriasis rosea. ( 26500862 )
2015
22
Pityriasis rosea. ( 26514823 )
2015
23
Acyclovir in pityriasis rosea: An observer-blind, randomized controlled trial of effectiveness, safety and tolerability. ( 26009712 )
2015
24
Pigmentogenes Pityriasis Rosea. ( 26584426 )
2015
25
Pityriasis Rosea in Children: Clinical Features and Laboratory Investigations. ( 25997658 )
2015
26
The Role of Cytokines, Chemokines, and Growth Factors in the Pathogenesis of Pityriasis Rosea. ( 26451078 )
2015
27
Segmental pityriasis rosea within the area of BRAF-mutated metastatic melanoma. ( 26446380 )
2015
28
Terbinafine induced pityriasis rosea-like eruption. ( 26729964 )
2015
29
Pityriasis rosea-like cutaneous eruption as the presenting symptom of Hodgkin lymphoma. Case report and review of the literature. ( 26512305 )
2015
30
The diagnostic criteria of pityriasis rosea and Gianotti-Crosti syndrome - a protocol to establish diagnostic criteria of skin diseases. ( 26517103 )
2015
31
The efficacy of macrolides and acyclovir in pityriasis rosea. ( 25566900 )
2015
32
Persistent pityriasis rosea: an unusual form of pityriasis rosea with persistent active HHV-6 and HHV-7 infection. ( 25612842 )
2015
33
Author's Response--The efficacy of azithromycin in pityriasis rosea: a randomized, double-blind, placebo-controlled trial. ( 25566901 )
2015
34
Nomenclature of drug-induced pityriasis rosea-like rashes. ( 26491333 )
2015
35
Pityriasis rosea following human papillomavirus vaccination. ( 25527111 )
2015
36
Facial involvement in Pityriasis Rosea. ( 26584310 )
2015
37
An atypical case of pityriasis rosea gigantea after influenza vaccination. ( 24847250 )
2014
38
The prevalence of herpes zoster and pityriasis rosea in patients with psoriasis: a preliminary study. ( 25353629 )
2014
39
A Randomized, Double-blind, Placebo-Controlled Study of Efficacy of Oral Acyclovir in the Treatment of Pityriasis Rosea. ( 24995231 )
2014
40
Multiple recurrences in pityriasis rosea - a case report with review of the literature. ( 24891682 )
2014
41
Efficacy of clarithromycin in pityriasis rosea. ( 25404436 )
2014
42
Pityriasis rosea like drug rash - a need to identify the disease in childhood. ( 25302254 )
2014
43
Pityriasis rosea-like arranged eruption after infliximab therapy in a patient with psoriasis vulgaris. ( 24617533 )
2014
44
The saliva quantitative PCR assay is inadequate to detect and monitor human herpesvirus-7 and -6 reactivation in patients with Pityriasis rosea. ( 25453575 )
2014
45
Decreased Serum Level of Interferon-I^ in Patients with Pityriasis Rosea. ( 25143687 )
2014
46
Pityriasis rosea and pityriasis rosea-like eruptions. ( 24355268 )
2014
47
Unilateral pityriasis rosea. ( 25396152 )
2014
48
Pityriasis rosea and activation of latent herpesvirus infections. ( 24355270 )
2014
49
Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature. ( 25545307 )
2014
50
Localized purpuric lesions in a case of classical pityriasis rosea. ( 25382521 )
2014

Variations for Pityriasis Rosea

Expression for Pityriasis Rosea

Search GEO for disease gene expression data for Pityriasis Rosea.

Pathways for Pityriasis Rosea

Pathways related to Pityriasis Rosea according to GeneCards Suite gene sharing:

(show all 34)
id Super pathways Score Top Affiliating Genes
1
Show member pathways
13.77 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
2
Show member pathways
13.23 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
3
Show member pathways
13.13 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
4
Show member pathways
12.95 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
5
Show member pathways
12.81 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
6
Show member pathways
12.72 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
7
Show member pathways
12.69 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
8
Show member pathways
12.6 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
9
Show member pathways
12.48 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
10
Show member pathways
12.46 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
11
Show member pathways
12.36 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
12
Show member pathways
12.31 HLA-A HLA-B HLA-C
13
Show member pathways
12.29 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
14
Show member pathways
12.28 HLA-A HLA-B HLA-C
15
Show member pathways
12.25 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
16 12.24 HLA-A HLA-B HLA-C
17 12.21 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
18
Show member pathways
12.17 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
19 12.14 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
20 12.13 HLA-A HLA-B HLA-C
21
Show member pathways
12.11 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
22
Show member pathways
12.02 HLA-A HLA-B HLA-C
23 12.01 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
24 11.94 HLA-A HLA-B HLA-C
25
Show member pathways
11.9 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
26 11.86 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
27
Show member pathways
11.85 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
28 11.82 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
29 11.78 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
30 11.68 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
31 11.65 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
32 11.51 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
33 11.33 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
34 11.14 HLA-A HLA-B HLA-C

GO Terms for Pityriasis Rosea

Cellular components related to Pityriasis Rosea according to GeneCards Suite gene sharing:

(show all 19)
id Name GO ID Score Top Affiliating Genes
1 endoplasmic reticulum GO:0005783 9.97 HLA-A HLA-B HLA-C HLA-DRB1 HLA-DRB5
2 Golgi apparatus GO:0005794 9.95 HLA-A HLA-B HLA-C HLA-DRB1 HLA-DRB5
3 cell surface GO:0009986 9.86 HLA-A HLA-B HLA-C HLA-DRB1
4 lysosomal membrane GO:0005765 9.8 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
5 endosome membrane GO:0010008 9.76 HLA-DQB1 HLA-DRB1 HLA-DRB5
6 trans-Golgi network membrane GO:0032588 9.76 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
7 early endosome membrane GO:0031901 9.71 HLA-A HLA-B HLA-C
8 endocytic vesicle membrane GO:0030666 9.71 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
9 late endosome membrane GO:0031902 9.7 HLA-DRB1 HLA-DRB4 HLA-DRB5
10 Golgi membrane GO:0000139 9.7 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
11 phagocytic vesicle membrane GO:0030670 9.69 HLA-A HLA-B HLA-C
12 transport vesicle membrane GO:0030658 9.67 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
13 recycling endosome membrane GO:0055038 9.65 HLA-A HLA-B HLA-C
14 clathrin-coated endocytic vesicle membrane GO:0030669 9.62 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
15 MHC class I protein complex GO:0042612 9.61 HLA-A HLA-B HLA-C
16 MHC class II protein complex GO:0042613 9.56 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
17 ER to Golgi transport vesicle membrane GO:0012507 9.5 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
18 integral component of lumenal side of endoplasmic reticulum membrane GO:0071556 9.17 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4
19 plasma membrane GO:0005886 10.12 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4

Biological processes related to Pityriasis Rosea according to GeneCards Suite gene sharing:

(show all 17)
id Name GO ID Score Top Affiliating Genes
1 viral process GO:0016032 9.86 HLA-A HLA-B HLA-C HLA-DRB1
2 immune system process GO:0002376 9.83 HLA-A HLA-B HLA-C HLA-DRB1 HLA-DRB5
3 T cell receptor signaling pathway GO:0050852 9.76 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
4 regulation of immune response GO:0050776 9.74 HLA-A HLA-B HLA-C
5 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent GO:0002479 9.72 HLA-A HLA-B HLA-C
6 antigen processing and presentation of exogenous peptide antigen via MHC class II GO:0019886 9.71 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
7 type I interferon signaling pathway GO:0060337 9.69 HLA-A HLA-B HLA-C
8 antigen processing and presentation of peptide antigen via MHC class I GO:0002474 9.65 HLA-A HLA-B HLA-C
9 immune response GO:0006955 9.63 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB5
10 T cell costimulation GO:0031295 9.62 HLA-DQB1 HLA-DRB1 HLA-DRB4 HLA-DRB5
11 humoral immune response mediated by circulating immunoglobulin GO:0002455 9.54 HLA-DQB1 HLA-DRB1
12 antigen processing and presentation of peptide or polysaccharide antigen via MHC class II GO:0002504 9.54 HLA-DQB1 HLA-DRB1 HLA-DRB5
13 protection from natural killer cell mediated cytotoxicity GO:0042270 9.52 HLA-A HLA-B
14 immunoglobulin production involved in immunoglobulin mediated immune response GO:0002381 9.49 HLA-DQB1 HLA-DRB1
15 antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent GO:0002480 9.43 HLA-A HLA-B HLA-C
16 antigen processing and presentation GO:0019882 9.43 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB5
17 interferon-gamma-mediated signaling pathway GO:0060333 9.17 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB4

Molecular functions related to Pityriasis Rosea according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 receptor binding GO:0005102 9.33 HLA-A HLA-B HLA-C
2 peptide antigen binding GO:0042605 9.1 HLA-A HLA-B HLA-C HLA-DQB1 HLA-DRB1 HLA-DRB5
3 MHC class II receptor activity GO:0032395 8.96 HLA-DQB1 HLA-DRB1

Sources for Pityriasis Rosea

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....